Zobrazeno 1 - 10
of 30
pro vyhledávání: '"R. A. KRANCE"'
Autor:
R. A. Krance, H. Mahmoud, R. L. Blakley, F. G. Behm, D. K. Srivastava, David R. Head, W. M. Roberts, Kristine R. Crews, S. C. Raimondi, R. C. Ribeiro, X. Tong, Craig A. Hurwitz
Publikováno v:
Journal of Clinical Oncology. 19:2804-2811
PURPOSE: To develop more effective chemotherapy regimens for childhood acute myelogenous leukemia (AML). PATIENTS AND METHODS: Between June 1991 and December 1996, we administered the nucleoside analog 2-chlorodeoxyadenosine (2-CDA) to 73 children wi
Autor:
V M, Santana, C A, Hurwitz, R L, Blakley, W R, Crom, X, Luo, W M, Roberts, R, Ribeiro, H, Mahmoud, R A, Krance
Publikováno v:
Blood. 84:1237-1242
The majority of children with acute myeloid leukemia (AML) who are treated exclusively with chemotherapy die of progressive disease. Improvement in outcome will likely require new active drugs capable of eradicating resistant blast cells early in the
Autor:
D R, Rill, R C, Moen, M, Buschle, C, Bartholomew, N K, Foreman, J, Mirro, R A, Krance, J N, Ihle, M K, Brenner
Publikováno v:
Blood. 79:2694-2700
Autologous bone marrow transplantation (ABMT) is widely used as treatment for malignant disease. Although the major cause of treatment failure is relapse, it is unknown if this arises entirely because of residual disease in the patient or whether con
Publikováno v:
Blood. 83:1706-1708
Autor:
I, Kuehnle, M H, Huls, Z, Liu, M, Semmelmann, R A, Krance, M K, Brenner, C M, Rooney, H E, Heslop
Publikováno v:
Blood. 95(4)
After bone marrow transplantation (BMT) using T-cell-depleted marrow from an unrelated donor or HLA-mismatched related donor, the risk of developing lymphoproliferative disease associated with the Epstein-Barr virus (EBV) ranges from 1% to 25%. We ha
Autor:
C M, Rooney, C A, Smith, C Y, Ng, S K, Loftin, J W, Sixbey, Y, Gan, D K, Srivastava, L C, Bowman, R A, Krance, M K, Brenner, H E, Heslop
Publikováno v:
Blood. 92(5)
Epstein-Barr virus (EBV) causes potentially lethal immunoblastic lymphoma in up to 25% of children receiving bone marrow transplants from unrelated or HLA-mismatched donors. Because this complication appears to stem from a deficiency of EBV-specific
Autor:
L. Ingram, W. C. Wang, G. C. F. Chan, David R. Head, R. A. Krance, Susana C. Raimondi, Frederick G. Behm, D. Butler, A. Freiberg, G. Chen
Publikováno v:
Leukemia. 11(2)
To evaluate diagnostic criteria, disease characteristics, and the clinical course of pediatric myelodysplastic syndrome (MDS), we reviewed 327 consecutive cases diagnosed with de novo acute myeloid leukemia (AML) or MDS at St Jude Children's Research
Autor:
J R, Kane, D R, Head, L, Balazs, M G, Hulshof, T A, Motroni, S C, Raimondi, A J, Carroll, F G, Behm, R A, Krance, S A, Shurtleff, J R, Downing
Publikováno v:
Leukemia. 10(8)
Acute promyelocytic leukemia (APL) is characterized cytogenetically by the t(15;17)(q22;q11-21) translocation. To compare molecular events among pediatric and adult APL cases, we designed two sets of oligonucleotide primers using published cDNA seque
Autor:
M E, Cela, M S, Holladay, C M, Rooney, S, Richardson, B, Alexander, R A, Krance, M K, Brenner, H E, Heslop
Publikováno v:
Bone marrow transplantation. 17(2)
The recovery of gamma delta T lymphocytes was studied in 31 recipients of T cell-depleted allogeneic bone marrow (BMT) to determine if the dynamics of reconstitution could be related to graft-versus-host disease (GVHD) or other complications of marro
Publikováno v:
Radiologic clinics of North America. 34(1)
Many of the pulmonary complications that we have described have a nonspecific radiographic appearance. The most crucial information for proper interpretation of the chest radiographs is the chronologic onset of radiographic abnormalities after transp